Single administration of novel antibody cocktail controlled patients' allergic response to cat allergen, preventing early asthma reactions for the duration of the 3-month trial Patients experienced ...

Regeneron Pharmaceuticals released positive Phase 2 trial results, which showed that a single dose of of its investigational antibody cocktail therapy prevented early asthma reactions in cat-allergic ...

Please provide your email address to receive an email when new articles are posted on . A single dose of Regeneron’s REGN1908/1909 significantly prevented reductions in FEV1 compared with placebo.

With the inclusion of the BATURA study, Airsupra has now demonstrated its effectiveness in reducing the risk of severe exacerbations across all severity levels of asthma vs albuterol. The Food and ...